Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8

Inagaki, Katsuya, Fuess, Sally, Storm, Theresa A., Gibson, Gregory A., Mctiernan, Charles F., Kay, Mark A., Nakai, Hiroyuki·2006·Molecular Therapy
DOI 10.1016/j.ymthe.2006.03.014

Cited by (613)

Items 501–600 of 613

  1. AAV-microutrophin gene therapy confers durable cardioprotection against pharmacologic and exercise-induced injury in the mdx mouse
    Coral M. Kasden, María P Corzo, Christopher D. Greer, Tanvi Singh, Rufranshell Reyes, Alaine Castillo, Zoltan Pierre Arany, Benjamin W. Kozyak, Hansell H. Stedman · 2025 · Molecular Therapy
  2. High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa
    Kuo-An Liao, Sang-oh Han, Mercedes Barzi, Haiqing Yi, William Eisner, Beatrice Bissig-Choisat, Karl‐Dimiter Bissig, Baodong Sun · 2025 · Molecular Therapy — Methods & Clinical Development
  3. Preclinical Assessment of Antibody Responses to Adeno-Associated Virus (AAV) Vector-Based Capsids of AAV2, AAV5, AAV8, or AAV9 in Laboratory Cynomolgus Macaques ( Macaca fascicularis ) of Asian or Mauritian Origin
    Betina Pajaziti, Ulf Michgehl, Dragica Blazevic, Franziska Fimm-Todt, A. Dütting, Birgit Korbmacher, Stephanie Grote-Wessels, Stefan Michelfelder, Lars Mecklenburg · 2025 · Human Gene Therapy
  4. Gene Therapies in Atrial Fibrillation
    Cian O’Donnell, Aleksei Mikhailov, Shin Yoo, Asish K. Ghosh, Rishi Arora · 2025 · Journal of Cardiovascular Translational Research
  5. Recombinant adeno-associated virus serotype 9 with p65 ribozyme protects H9c2 cells from oxidative stress through inhibiting NF-κB signaling pathway.
    Zhan Sun, Yi-Tong Ma, Bang‐Dang Chen, Fen Liu · 2014 · Europe PMC (PubMed Central)
  6. Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti‐inflammatory drugs
    Wolfgang C. Poller, Madlen Rother, Carsten Skurk, Carmen Scheibenbogen · 2011 · British Journal of Pharmacology
  7. Progress and Challenges in AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
    Shin’ichi Takeda, Takashi Ok · 2011 · InTech eBooks
  8. AAV-Based Targeting Gene Therapy
    Wenfang Shi, Mingxia Yu, Qijun Qian · 2008 · American Journal of Immunology
  9. Therapeutic delivery of cyclin-A2 via recombinant adeno-associated virus serotype 9 restarts the myocardial cell cycle: An in vitro study
    Xiang Ma, Aichao Zhao, YONGZHAO YAO, Wen Cao, Ujit Karmacharya, Fen Liu, Bang‐Dang Chen, WANG BAOZHU, Huang Ying, Yitong Ma · 2015 · Molecular Medicine Reports
  10. Methods for Noninvasive Monitoring of Muscle Fiber Survival with an AAV Vector Encoding the mSEAP Reporter Gene
    Jérôme Poupiot, Jérôme Ausseil, Isabelle Richard · 2010 · Methods in molecular biology
  11. Genetic Vaccines and Therapy
    Lourdes M. Andino, Thomas J. Conlon, Stacy Porvasnik, Sanford L. Boye, William W. Hauswirth, Alfred S. Lewin · 2015
  12. The Anti-apoptotic Role of 3′-Untranslational Region in Response to Angiotensin II via Mcl1 Expression
    Dayin Lyu, Hong Yan, Liyang Chen, Lingmin Zhang, Yanfeng Du, Lexi Ding, Qiulun Lu · 2021 · Frontiers in Cell and Developmental Biology
  13. Viral vectors for gene delivery
    Katharine J. Liang, Richard Jude Samulski · 2015
  14. Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors
    Rajvinder Karda, Ahad A. Rahim, Andrew M.S. Wong, Natalie Suff, Juan F. Antinao Diaz, Dany P.B. Perocheau, Nuria Palomar, Michael P. Hughes, Juliette M. K. M. Delhove, John Robert Counsell et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Generation of Atrial-Specific Construct Using Sarcolipin Promoter-Associated CRM4 Enhancer
    Dongtak Jeong · 2022 · Methods in molecular biology
  16. Fine-tuned phenylboronic acid polymer assembly with tannic acid enables adeno-associated virus to evade and suppress neutralizing antibody responses
    Yao Xiao, Yuto Honda, Nozomi Matsudaira, Hiroaki Kinoh, Xin Shen, Guo Haochen, Hiromi Hayashita-Kinoh, Shan Gao, Aziz Awaad, Yutaka Miura et al. · 2026 · Journal of Controlled Release
  17. Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound
    Daesun Song, Marigold Gil Malinao, Xiang Wu, Shan Jiang, Dongyun Jiang, Michael Westberg, Yichi Su, Sa Cai, Dongin Lee, Nicole A. Repina et al. · 2026 · Cell
  18. The Development of an Ultrasound-mediated Nucleic Acid Delivery System for Treating Muscular Dystrophies
    Yoichi Negishi, Nobuhito Hamano, Hitomi Shiono, Saki Akiyama, Yoko Endo‐Takahashi, Ryo Suzuki, Kazuo Maruyama, Yukihiko Aramaki · 2012 · YAKUGAKU ZASSHI
  19. Gene- and Cell-Based Therapy for Cardiovascular Disease
    José Marı́n-Garcı́a · 2014 · Elsevier eBooks
  20. Elimination of Mutant Mitochondrial DNA in Mitochondrial Myopathies Using Gene-Editing Enzymes
    Sandra R. Bacman, Carlos Torres Moraes · 2019 · Springer eBooks
  21. Systemic Gene Delivery for Muscle Gene Therapy
    Dilip K. Garikipati, Jeffrey S. Chamberlain · 2009 · Springer eBooks
  22. Transduction of non-human primate brain with adeno-associated virus serotype 1: vector trafficking and immune response
    Piotr Hadaczek, John Forsayeth, Hanna Mirek, Keith Munson, John Bringas, Philip Pivirotto, Jodi L. McBride, Beverly L. Davidson, Krystof S. Bankiewicz · 2008 · Human Gene Therapy
  23. Long‐Term Correction of Murine Glycogen Storage Disease Type III by AAV‐Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial Pullulanase
    Kuo An Liao, Jeong‐A Lim, Su Jin Choi, Haiqing Yi, Baodong Sun · 2025 · Advances in Cell and Gene Therapy
  24. Construction of an Indole-induced Transgenic System and Its Therapeutic Effects on Allergic Rhinitis
    Guangyao Li, Shengju Li, Fangzhou Ye, Keguang Chen, Hongmeng Yu · 2025 · American Journal of Respiratory Cell and Molecular Biology
  25. Gene therapy to the kidney using viral vectors.
    Talha Akbulut, Frank Park · 2008 · PubMed
  26. Serotypy wirusów związanych z adenowirusami
    Agnieszka Lipiec, Maciej Małecki, Karolina Hajdukiewicz · 2009 · Postępy Biochemii
  27. Gene Therapy of the Heart through Targeting Non-Cardiac Cells
    Guro Valen · 2011 · InTech eBooks
  28. Genetic and Cell-Mediated Therapies for Duchenne Muscular Dystrophy
    Jacopo Baglieri, Carmen Bertoni · 2015 · Elsevier eBooks
  29. XPO1 gene therapy restores cardiac function in rats with chronic induced myocardial infarction
    Maria García‐Manzanares, Carolina Gil‐Cayuela, Luis Martínez‐Dolz, José Ramón González‐Juanatey, Francisca Lago, Manuel Portolés, Esther Roselló‐Lletí, Miguel Rivera · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Oxidized LDL but not angiotensin II induces the interaction between LOX-1 and AT1 receptors
    Lin Li, Ning Zhou, Le Kang, Qi Wang, Jian Wu, Xiaoyan Wang, Chunjie Yang, Guoping Zhang, Yunqin Chen, Hong Jiang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Induced Proteinuria Enhances Adeno-Associated Virus Transduction of Renal Tubule Epithelial Cells After Intravenous Administration
    Jeffrey D. Rubin, Katayoun Ayasoufi, Erin B. McGlinch, Michael J. Hansen, Peter C. Harris, Vicente E. Torres, Michael A. Barry · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Tachyarrhythmia Therapies: Approaches to Atrial Fibrillation and Postinfarction Ventricular Arrhythmias
    J. Kevin Donahue, Kenneth R. Laurita · 2011 · Humana Press eBooks
  33. Advantages of Catheter-Based Adenoviral Delivery of Genes to the Heart for Studies of Cardiac Disease
    J. Michael · 2012 · InTech eBooks
  34. IN UTERO GENE DELIVERY OF AAV VECTORS FOR EFFICIENT TREATMENT OF MUSCLE DISORDERS
    Bhanu Munil Koppanati · 2010 · D-Scholarship@Pitt (University of Pittsburgh)
  35. Rapidly evolving adeno-associated virus vectors: increasing possibility of gene therapy with custom-made vectors
    Hiroyuki Nakai · 2009 · Drug Delivery System
  36. Gene Therapy and Muscles: The Use of Adeno-associated Virus—Where are We Today?
    Bing Wang · 2010 · Operative Techniques in Orthopaedics
  37. Cardiac Delivery of Nucleic Acids by Transcriptional and Transductional Targeting of Adeno-Associated Viral Vectors
    Oliver Josef Müller, Hugo Albert Katus · 2008 · Springer eBooks
  38. ADVANCES IN MOLECULAR THERAPY RESEARCH ON DYSTROPHIN-DEFICIENT MUSCULAR DYSTROPHY
    Takashi Okada, Shin’ichi Takeda · 2010 · Gene Therapy and Regulation
  39. Gene Transfer of the Sarcoplasmic Reticulum Pump in the Treatment of Heart Failure
    Gerd P Hasenfuss · 2011 · European Journal of Heart Failure
  40. Gene therapy for Duchenne muscular dystrophy
    Naoki Suzuki, Yuko Miyagoe‐Suzuki, Shin’ichi Takeda · 2006 · Future Neurology
  41. Gene Therapy for Very Long Chain Acyl-coA Dehydrogenase Deficiency Using Adeno-Associated Virus Vectors: A Dissertation
    Allison M. Keeler · 2012 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  42. Continuing on the road to health: a short history of the Charité–universitätsmedizin Berlin from a plague house in the past to a medical school with a future
    Ernst Peter Fischer · 2008 · Journal of Molecular Medicine
  43. AAV2 vermittelte Transduktion von porcinem Myokard im Transplantationsmodell
    Schulz, Alexandra · 2009 · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)
  44. Myokardialer Gentransfer mittels Adenoassoziierter Viraler Vektoren
    Gerhard Steinbeck · 2012
  45. Emerging Gene Correction Strategies for Muscular Dystrophies: Scientific Progress and Regulatory Impact
    Houria Bachtarzi, Tim Farries · 2016 · InTech eBooks
  46. Alternative Therapeutic Modalities in Treatment of Ischemic Heart Disease: Experimental studies on retinoic acid signaling in myocardial remodelling and remote gene therapy using heme oxygenase-1
    Dusan Bilbija · 2013 · NORA - Norwegian Open Research Archives
  47. A Translational Pathway for Recombinant Adeno-Associated Virus Human Gene Therapy: From Target Identification and Animal Modeling of the Disease to Non-Human Primate and Human Studies
    Alisha M. Gruntman · 2016 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  48. Gene therapy in mouse models of spinal muscular atrophy :||using SMN gene replacement to address biological questions
    Jacqueline Glascock · 2013
  49. UNCOVERING STRUCTURAL COMPONENTS OF THE ADENO-ASSOCIATED VIRAL CAPSID THAT CAN BE MODIFIED TO IMPROVE CLINICAL GENE THERAPY OUTCOMES
    Jayme K. Warischalk · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  50. Experimental studies on retinoic acid signaling in myocardial remodelling and remote gene therapy using heme oxygenase-1
    Dusan Bilbija · 2012
  51. 基于CRISPR/Cas9基因编辑技术的人类遗传疾病基因治疗相关研究进展
    可 门, 醒妹 段, 阳 杨, 于全 魏 · 2017 · Scientia Sinica Vitae
  52. Targeting the ubiquitin proteasome system to develop novel therapeutic approaches for spinal muscular atrophy
    Rachael A. Powis · 2016 · Edinburgh Research Archive (University of Edinburgh)
  53. Paracrine Engineering of Human Cardiac Stem Cells with Insulin-Like Growth Factor 1 Promotes Cell Survival to Enhance Myocardial Repair
    Robyn Jackson · 2014 · uO Research (University of Ottawa)
  54. AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models
    Katharine J. Liang · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  55. DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
    Blake H. Albright · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  56. Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got?
    H. Kirk Hammond, Tong Tang · 2009 · PubMed
  57. Gene therapy of muscular dystrophy: systemic gene delivery to skeletal muscles
    Katsutoshi Yuasa, Takao Hijikata, Shin’ichi Takeda · 2007 · Drug Delivery System
  58. MitoTALENs for mtDNA editing
    Sandra R. Bacman, Carlos Torres Moraes · 2020 · Elsevier eBooks
  59. Molecular therapies for bradyarrhythmias
    Anna M. D. Végh, Harsha D. Devalla, Dirk Geerts, Hanno L. Tan, Vincent M. Christoffels, Marie‐José Goumans, Gerard J.J. Boink · 2020 · Elsevier eBooks
  60. Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
    Natascha Schuhmann · 2008 · Kölner Universitäts PublikationsServer (Universität zu Köln)
  61. Translating molecular therapies for spinal muscular atrophy
    Brian K. Kaspar · 2020 · Elsevier eBooks
  62. The role of microRNA-378 in cardiac hypertrophy
    Jayavarshni Ganesan · 2014 · Online Publication Service of Würzburg University (Würzburg University)
  63. Current World Literature
    2007 · Current Opinion in Neurology
  64. Faculty Opinions recommendation of A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
    David Evans · 2009 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. Bioengineering Adeno-Associated Viral Vectors for the Targeted Expression of Therapeutic Genes
    Nathan Thomas · 2014
  66. Characterization of PPAR-alpha overexpression in beta-cell lipotoxicity and its effects on obesity-induced type 2 diabetes.
    K‐Lynn N. Hogh · 2012
  67. PPARδ regulates insulin secretion in pancreatic β-cells : evidence from an in-vivo mouse model of β-cell specific PPARδ overexpression
    Maryam Khan · 2016
  68. CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy
    Simon Guiraud, Sumitava Dastidar, Fetta Mazed, Fatima Amor, Maëlle Ralu, Anne De Cian, Isabelle Richard, Giuseppe Ronzitti, Francesco Saverio Tedesco, Mario Amendola · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  69. LncRNA Bigheart trans-activates gene expression in a feed forward mechanism that facilitates calcineurin-NFAT signaling in myocardial hypertrophy
    Nicolò Mangraviti, Frank Rühle, Virginie Kinet, Jana-Charlotte Hegenbarth, Ellen Dirkx, Giulia Spanò, Federica De Majo, Panagiotis Peppas, Leonie Martens, Shrey Gandhi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  70. MyoRep: A Novel Reporter System to Detect Early Muscle Atrophy In Vitro and In Vivo
    Andrea David Re Cecconi, Nicoletta Rizzi, Mara Barone, Federica Palo, Martina Lunardi, Mara Forti, Adriana C. Maggi, Paolo Ciana, Giulia Terribile, Michela Chiappa et al. · 2026 · Journal of Cachexia Sarcopenia and Muscle
  71. Generation and Treatment of a Novel Severe Model of Visceral Gaucher Disease by Genetic Therapy
    Amy F. Geard, Giulia Massaro, Michael P. Hughes, Patrick B. Arbuthnot, Simon N. Waddington, Ahad A. Rahim · 2025 · Pharmaceutics
  72. Decoding Cellular Diversity in Skeletal Muscle: Impacts on Muscle Function, Adaptation, and Disease
    Hilal Kalkan · 2025 · IntechOpen eBooks
  73. Additional file 2 of EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
    Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Perin, Martina, Andrea Colliva et al. · 2024 · Figshare
  74. Additional file 2 of Comparative analysis of adeno-associated virus serotypes for gene transfer in organotypic heart slices
    Liu, Zihou, Kristin Klose, Sebastian Neuber, Jiang, Meng, Manfred Gossen, Christof Stamm · 2020 · Figshare
  75. Additional file 1 of EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
    Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Perin, Martina, Andrea Colliva et al. · 2024 · Figshare
  76. Additional file 4 of EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
    Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Perin, Martina, Andrea Colliva et al. · 2024 · Figshare
  77. Additional file 3 of EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
    Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Perin, Martina, Andrea Colliva et al. · 2024 · Figshare
  78. Additional file 1 of Comparative analysis of adeno-associated virus serotypes for gene transfer in organotypic heart slices
    Liu, Zihou, Kristin Klose, Sebastian Neuber, Jiang, Meng, Manfred Gossen, Christof Stamm · 2020 · Figshare
  79. Intermittent AP-1 activation in muscles contributes to exercise-induced health benefits
    Abhinav Choubey, S. Udhaya Kumar, Tingting Yang, Jennifer Jager, Sungguan Hong, Manashree Damle, Huiqi Yin, Ruxing Zhao, Chengchuang Song, Ege Sanem Oturmaz et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  80. A Rationally Designed AAV9-DM Capsid with Minimal Liver Tropism
    Zoe C. Nabakowski, Izabella C. Jaramillo, Primrose Tanachaiwiwat, Geoffrey D. Keeler · 2026 · Cells
  81. Intravenous rAAV9 Produces Time-Resolved Parenchymal Labeling Downstream of the Vasculature in Adult Mice
    Alejandro Soto-Avellaneda, Anton D. Pugel, Jocelyn R. Holmes, Alyssa Hicks, Sara Z. Alsaifi, Gyandarshika Koirala, Alexandra E. Oxford, Brad E. Morrison · 2026 · Biology
  82. A clinically relevant retrograde intraductal injection (RIDI) for lipid nanoparticles-mediated base editing in the pancreas
    Deepak Kumar Sahel, Amita Tiyaboonchai, Leslie Wakefield, Jonas Renner, Antony Jozić, Craig Dorrell, Kseniya Yu. Vlasova, Namratha Turuvekere Vittala Murthy, Markus Grompe, Gaurav Sahay · 2026 · Nanomedicine Nanotechnology Biology and Medicine
  83. Adeno-associated virus (AAV) mediated advanced therapeutic interventions for inherited and non-inherited cardiac disorders
    Indu Singh, Anil Kumar, Awdhesh Kumar Chaudhary, Jasbir Singh Dalal, Anusha Sharma, Juhi Sharma, Arun Ratn, Megh Singh Dhakad, Divakar Sharma · 2026 · Journal of the Renin-Angiotensin-Aldosterone System
  84. Mise au point d'outils novateurs pour l'identification de mutations pathogènes : le cas des dysferlinopathies
    Virginie Kergourlay · 2014 · theses.fr (ABES)
  85. Recombinant Adeno-Associated Viruses : process development and gene transfer application for muscular dystrophy
    Gabriella Dias Florencio Leite · 2017
  86. Développement préclinique d'une thérapie génique pro-angiogénique combinée de l'ischémie cardiaque et du membre inférieur
    Edith Renaud-Gabardos · 2016 · theses.fr (ABES)
  87. Stratégies de stimulation du transport axonal endogène du Bdnf comme piste thérapeutique dans le syndrome de Rett
    Yann Ehinger · 2018 · theses.fr (ABES)
  88. Cardiac gene therapy with phosphodiesterase PDE4B in a mouse model of heart failure
    Jean Piero Margaria · 2018
  89. When engineering new recombinant factor IX molecules meets gene therapy : improvement of factor IX plasma level in patients with haemophilia B?
    Sandra Le Quellec · 2018 · theses.fr (ABES)
  90. Thérapie génique de l'insuffisance cardiaque par les phosphodiestérases
    Aurélia Bourcier · 2019
  91. Développement d'un traitement de thérapie génique pour la glycogénose de type III
    Patrice Vidal · 2018
  92. Développement de nouvelles approches thérapeutiques pour la dystrophie musculaire de Duchenne, basées sur l'utilisation de vésicules extracellulaires
    Camille Vaubourg · 2020 · theses.fr (ABES)
  93. Balance entre rejet et tolérance : la bipolarité immunitaire du muscle squelettique face à l’AAV recombinant : décryptage de la réponse immune de l’hôte dirigée contre le produit du transgène après injection de vecteurs AAV recombinants par voie intramusculaire
    Malo Journou · 2021 · theses.fr (ABES)
  94. Identification des mécanismes moléculaires de neuroprotection modulés par l’activité dans deux maladies du motoneurone
    Zoé Clerc · 2024 · theses.fr (ABES)
  95. Characterizing flunarizine’s neuroprotection in spinal muscular atrophy : Implication of the RNA-binding protein GEMIN5
    Badih Salman · 2024
  96. Preclinical gene therapy using recombinant AAV vectors in mouse models of two human diseases
    Yasemin Özgür Günes · 2022 · theses.fr (ABES)
  97. Etude des réponses T CD8+ après transfert de gène par rAAV ciblant le muscle
    Lindsay Jeanpierre · 2024 · theses.fr (ABES)
  98. Inhibition of miR-320 alleviates hepatic steatosis and dyslipidemia via suppressing the transcription of APOE in MASLD
    Yufei Zhou, Guo Hu, Kunying Jin, Jianpei Wen, Hengzhi Du, Junfang Wu, Xiang Cheng, Xifei He, Limin Xia, Huaping Li et al. · 2026 · Biomedicine & Pharmacotherapy
  99. MiR-200a-3p protects against myocardial ischemia-reperfusion injury via KEAP1–NRF2 signaling
    Yanbo Zhao, Lulu Liu, Xiaohua Shen, Min Wang, Meihui Wang, Lingling Sun, Kai Zhang · 2026 · Frontiers in Physiology
  100. Systemic AAV8-SIL1-TAT therapy improves motor function in a mouse model of Marinesco-Sjögren syndrome
    Fabio Bellia, Anna Giulia Ruggieri, Laura Amodei, Francesca Potenza, Beatrice Dufrusine, Valeria Panella, Francesco Pizzo, Alessia Lamolinara, Manuela Iezzi, Luca Federici et al. · 2026 · Biochemical Pharmacology